James McLaughlin

James Mclaughlin (Member, IEEE) is the Director of the Nanotechnology and Integrated-Bioengineering Centre (NIBEC), Ulster University, Newtownabbey, U.K, where he is also the Head of the School of Engineering. His world-leading Digital-Healthcare-Technology research addresses nanotechnology and its application in areas such as cardiac point-of-care sensors and medical diagnostics. Prof. McLaughlin with an H-Index of 48, over 400 publications, and 35 patents has attracted over £70 m of funding (EU, EPSRC, Wellcome Trust, InnovateUK; INI; US-Irl, etc.) to pioneer research that has led to the establishment of NIBEC, CHIC, NICAM, NanotecNI, ECME, Biodevices Lab, and BEST Centre. He is the co-founder of various successful companies, including the wireless-patient-monitoring company, Intelesens, Heartscape, SiSaF, and the initial phases of Heartsine. He also led the successful global XPRIZE Tricorder Zensor team to overall 3rd position and has developed a wide range of industrial and international academic collaborations, particularly in the areas of nanotechnology, cardiovascular monitoring, and diagnostics. He is currently heading up the new Belfast City Region Deal—Centre for Digital Healthcare Technologies. Prof. McLaughlin is a Fellow of the Institute of Physics and the Irish Academy of Engineering. He was awarded an Officer of the Most Excellent Order of the British Empire (OBE) for his services to Research and Economic-Development and Commander of the Most Excellent Order of the British Empire (CBE) for Research and Education in 2022. He is a Senior Distinguished Fellow. He sits on a wide range of boards, funding councils, and served on NI MATRIX for ten years.